The blockade of interleukin‐33 released by hepatectomy would be a promising treatment option for cholangiocarcinoma

Interleukin‐33 (IL‐33), an alarmin released during tissue injury, facilitates the development of cholangiocarcinoma (CCA) in a murine model. However, it is unclear whether IL‐33 is associated with human CCA. The aim of this study was to support the following hypothesis: IL‐33 is released during hepa...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagaoka, Satoshi, Yamada, Daisaku, Eguchi, Hidetoshi, Yokota, Yuki, Iwagami, Yoshifumi, Asaoka, Tadafumi, Noda, Takehiro, Kawamoto, Koichi, Gotoh, Kunihito, Kobayashi, Shogo, Miyoshi, Eiji, Doki, Yuichiro, Mori, Masaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780022/
https://www.ncbi.nlm.nih.gov/pubmed/33098728
http://dx.doi.org/10.1111/cas.14709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780022/
https://www.ncbi.nlm.nih.gov/pubmed/33098728
http://dx.doi.org/10.1111/cas.14709

Ejemplares similares